Hepatitis B Journal Articles

• Risk of HBV Reactivation in Patients With Severe COVID-19 Does immunosuppressive therapy for COVID-19 increase the risk of HBV reactivation in patients with resolved HBV infection?
  Journal of Viral Hepatitis, January 25, 2021
• Characteristics of COVID-19 and Concomitant HBV Infection This study details the epidemiology, clinical characteristics, treatment, and outcome of a cohort of patients with both SARS-CoV-2 and HBV infection.
  Journal of Viral Hepatitis, January 18, 2021
• SARS-CoV-2 Infection in Patients With Normal or Abnormal Liver This paper summarizes what we know about SARS-CoV-2 in patients with liver disease, as well as its impact on the healthy liver. How should management of liver patients change in the COVID-19 era?
  Journal of Viral Hepatitis, January 11, 2021
• Fatty Liver Disease-A Multifaceted Disease With Multiple Names? In this commentary, the authors suggest that a more precise terminology for NAFLD is needed, with a more granular view on subcategories of NASH to guide preventive and therapeutic measures.
  Liver International, January 07, 2021
• Newly Approved HIV Medications Review the novel antiretroviral drugs and drug combinations which have been recently approved for the treatment of HIV.
  U.S. Pharmacist, December 29, 2020
• 2019 Update of the EACS Guidelines for Treatment of HIV This article provides a summary of updates to the 2019 EACS guidelines regarding treatment recommendations for people living with HIV. Find out what's new.
  HIV Medicine, November 20, 2020
• Comparative Performance of SARS-CoV-2 Serology Tests This study compared the sensitivity and specificity of 7 commercially available SARS-CoV-2 serology assays used to document prior SARS-CoV-2 infections.
  American Journal of Clinical Pathology, November 17, 2020
• Impact of HCV Treatment on Risk of Non-hepatic Cancers Does HCV treatment significantly reduce incidence of non-hepatic cancers among patients with HCV infection?
  Alimentary Pharmacology & Therapeutics, November 16, 2020
• Outcomes of INSTIs, PI/bs and NNRTIs in ART-Naive Persons A new study compares the virological and immunological outcomes among individuals newly initiating ART with these regimens.
  HIV Medicine, November 06, 2020
• Viral Hepatitis Infection and Parkinson's Disease Might infection with HBV or HCV increase the risk of developing Parkinson's disease?
  Journal of Viral Hepatitis, November 06, 2020
• Mechanisms for Increased Diabetes Risk in Chronic Liver Disease Patients with both NAFLD and chronic hepatitis C are at high risk of developing diabetes. This study aimed to elucidate the underlying physiological mechanisms involved.
  Liver International, October 23, 2020
• HCV Core Antigen As an Alternative to HCV RNA Testing This study suggests that while implementation of HCV core antigen testing for diagnosis could lead to significant cost savings, it is not as sensitive as gold-standard PCR testing.
  Journal of Viral Hepatitis, October 23, 2020
• Vaccination Coverage Among U.S. Adolescents Aged 13-17 Data in this report indicates that adolescent vaccination coverage in the United States continues to improve for HPV and for meningococcal vaccines, but disparities remain.
  Morbidity & Mortality Weekly Report, October 21, 2020
• Abnormal Liver Function Tests and Outcomes in COVID-19 This study found that abnormal liver function tests are common in hospitalized patients with COVID-19 and strongly predict a worse clinical course of the disease
  Liver International, October 16, 2020
• Care Quality and Outcomes for Chronic HBV in the HCV DAA Era Has overall quality of care for HBV significantly improved in the era of widespread HCV direct-acting antiviral therapy?
  Journal of Viral Hepatitis, October 16, 2020
• Polypharmacy and Potential Drug-Drug Interactions for HIV Are you aware of the types of concurrent medications commonly prescribed to HIV patients and the potential drug-drug interactions?
  HIV Medicine, October 09, 2020
• Chronic Liver Disease and Outcomes of Patients With COVID-19 This study found that one in five patients hospitalized with COVID-19 had underlying chronic liver disease. What was the impact of CLD on COVID-19 symptoms and outcomes?
  Liver International, October 09, 2020
• The Role of C-Section in Mother-to-child Transmission of HBV Does cesarean section and nonbreastfeeding prevent mother-to-child transmission in HBV-positive mothers who did not receive antiviral therapy during pregnancy?
  Journal of Viral Hepatitis, October 09, 2020
• Liver Disease-related Mortality and Increased Coffee Drinking It's long been recognized that coffee intake offers some protection against liver disease. If coffee consumption were increased worldwide, how might it impact liver disease-associated mortality?
  Alimentary Pharmacology & Therapeutics, October 07, 2020
• Switching From TDF to TAF in HIV/HBV With Renal Dysfunction Is this treatment change an effective strategy for HIV/HBV-coinfected patients with impaired renal function?
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, October 01, 2020